Suppr超能文献

淀粉样蛋白前体向潜在淀粉样生成衍生物的加工过程。

Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

作者信息

Golde T E, Estus S, Younkin L H, Selkoe D J, Younkin S G

机构信息

Division of Neuropathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106.

出版信息

Science. 1992 Feb 7;255(5045):728-30. doi: 10.1126/science.1738847.

Abstract

The approximately 120-kilodalton amyloid beta protein precursor (beta APP) is processed into a complex set of 8- to 12-kilodalton carboxyl-terminal derivatives that includes potentially amyloidogenic forms with the approximately 4-kilodalton amyloid beta protein (beta AP) at or near their amino terminus. In order to determine if these derivatives are processed in a secretory pathway or by the endosomal-lysosomal system, (i) deletion mutants that produce the normal set of carboxyl-terminal derivatives and shortened secreted derivatives were analyzed and (ii) the effect of inhibitors of endosomal-lysosomal processing was examined. In the secretory pathway, cleavage of the beta APP occurs at a single site within the beta AP to generate one secreted derivative and one nonamyloidogenic carboxyl-terminal fragment, whereas, in the endosomal-lysosomal system, a complex set of carboxyl-terminal derivatives is produced that includes the potentially amyloidogenic forms.

摘要

约120千道尔顿的β淀粉样蛋白前体(βAPP)被加工成一组复杂的8至12千道尔顿的羧基末端衍生物,其中包括在其氨基末端或附近带有约4千道尔顿β淀粉样蛋白(βAP)的潜在淀粉样生成形式。为了确定这些衍生物是通过分泌途径还是通过内体 - 溶酶体系统进行加工的,(i)分析了产生正常羧基末端衍生物组和缩短的分泌衍生物的缺失突变体,(ii)研究了内体 - 溶酶体加工抑制剂的作用。在分泌途径中,βAPP在βAP内的单个位点发生切割,产生一种分泌衍生物和一个非淀粉样生成的羧基末端片段,而在内体 - 溶酶体系统中,则产生一组复杂的羧基末端衍生物,其中包括潜在的淀粉样生成形式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验